Published Date: 17 Feb 2023
Online dating has revolutionized dating by creating more opportunities to meet partners than ever before.
Read Full NewsWalter Kernan, MD, senior research scientist at Yale University, discussed the latest primary stroke prevention guidelines and their focus on lifelong brain health and risk factor management.
Andy Berkowski, MD, PhD, certified sleep neurologist and author of the RLS guidelines, spoke about the clinical impact of the recently published restless syndrome guidelines.
FDA Approves Depemokimab-ulaa (Exdensur) for Severe Asthma
Sleep Disorders Linked to Poorer Symptom Control in Severe Asthma
IgA Nephropathy Prediction Model Aids 5-Year Survival Estimation
Increased Physical Activity Linked to Reduced Mortality In Peritoneal Dialysis
GLP-1 RA Use Linked to 42% Hepatocellular Carcinoma Risk Reduction in T2DM
1.
How the skin cancer virus outperforms the replication of host cells.
2.
The risk of ovarian cancer is not increased by salpingectomy, according to JAMA.
3.
New methods show how fast breast cancers grow and how surgery delays affect cancer staging
4.
Study shows supervised exercise improves strength, physical performance in patients with advanced breast cancer
5.
High Rate of Deep Remission for Relapsed/Refractory CLL Using Triple Regimen.
1.
Demystifying the Mentzer Index: Understanding Its Importance in Inventory Management
2.
Immunotherapy Breakthroughs: Transforming Cancer Care Across All Oncology Fields
3.
RDW-CV vs. MCV: Knowing the Difference Can Help You Better Understand Your Health
4.
Harnessing Artificial Intelligence in Oncology: Innovations in Diagnosis, Treatment, and Patient Care
5.
Oncological Surgery Today: Personalized, Interdisciplinary Approaches to Cancer Care
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
2.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part II
4.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion
5.
Navigating the Complexities of Ph Negative ALL - Part X
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation